Multiple Sclerosis

Multiple sclerosis (MS) is a chronic, often unpredictable disease that affects the central nervous system (CNS)—which includes the brain, spinal cord, and optic nerves. It’s classified as an autoimmune disorder, meaning the body’s immune system mistakenly attacks its own tissues. In the case of MS, the immune system targets the myelin sheath, a protective layer that surrounds nerve fibers. This damage disrupts the normal flow of electrical signals in the CNS, leading to a wide variety of neurological symptoms. Depending on where the damage occurs, symptoms can include numbness, vision problems, muscle weakness, balance issues, fatigue, or even cognitive changes.

The course of MS can vary dramatically from person to person. There are a few main types: relapsing-remitting MS (RRMS) is the most common and involves clear flare-ups (relapses) followed by periods of recovery (remission). Others may experience secondary progressive MS (SPMS), where the disease gradually worsens over time, or primary progressive MS (PPMS), which is progressive from the start without distinct relapses. The exact cause of MS isn’t fully understood, but it’s thought to involve a mix of genetic predisposition and environmental triggers—like certain viruses (e.g., Epstein-Barr), low vitamin D levels, and possibly smoking. MS is more common in women and often starts between the ages of 20 and 40.

Treatment focuses on managing symptoms, modifying the disease course, and improving quality of life. Disease-modifying therapies (DMTs) are the cornerstone for many patients—they help reduce the frequency and severity of relapses and slow progression. These drugs include injectable medications, oral pills, and infusion-based therapies. Alongside that, physical therapy, lifestyle changes (like staying active and managing stress), and medications for specific symptoms (like spasticity or fatigue) all play a role. While there’s currently no cure, ongoing research in immunology, stem cells, and remyelination techniques is offering a lot of hope for better treatments—and maybe even a cure—in the future.

.

{openx:185}

Most Useful Resources:
Multiple Sclerosis (Podiatry Arena)
Multiple Sclerosis (PodiaPaedia)
Multiple Sclerosis (Foot Health Forum)
Multiple Sclerosis Diagnosis & Management (Podiatry Apps)

{openx:185}

Burning Feet

The symptoms of a burning foot or feet are almost always due to some underlying neurological problem. The treatment options are often limited and the problem can be quite distressing.

{openx:185}

Burning feet is a sensation often described as warmth, tingling, or even a painful burning feeling in the soles or toes. This condition can range from mild discomfort to severe pain that interferes with daily activities and sleep. The sensation may be constant or intermittent and is usually more noticeable at night. While it is not a disease on its own, burning feet is a symptom that can point to various underlying issues.

One of the most common causes of burning feet is peripheral neuropathy, a condition in which the nerves that transmit signals between the body and the brain are damaged. This can result from diabetes, chronic alcohol use, vitamin deficiencies (particularly B vitamins), or exposure to toxins. Neuropathy leads to abnormal nerve firing, causing sensations of burning, numbness, or tingling. Since diabetes is a leading global cause, burning feet is often considered a warning sign of diabetic nerve damage.

Other possible causes include circulatory problems, fungal infections such as athlete’s foot, kidney disease, thyroid dysfunction, or even mechanical issues like nerve entrapment in the lower back or legs. Some people may also experience burning feet due to prolonged standing, poorly fitting footwear, or excessive exercise. In rare cases, autoimmune conditions and certain medications can also trigger the symptom. Because of this wide range, identifying the exact cause requires careful medical evaluation.

Management of burning feet depends on addressing the underlying cause. For example, strict blood sugar control can slow or prevent further nerve damage in diabetics, while vitamin supplements may help in cases of deficiency. Symptom relief may involve cooling foot baths, comfortable footwear, and topical or oral medications to reduce nerve pain. In persistent or worsening cases, seeking medical advice is important, as untreated neuropathy or circulation issues can lead to serious complications.

Most Useful Resources:
Burning Feet (Foot Health Forum)
Burning feet (Podiatry Arena)
Reasons for burning feet (Podiatry Arena)
Burning Feet (PodiaPaedia)
Burning foot (ePodiatry)
De Agony of De Burning Feet (Foot Health Friday)
Burning Feet (Podiatry Ninja)

{openx:185}

Baxters Nerve Entrapment

Baxter nerve entrapment is a cause of heel pain with the symptoms often mimicking plantar fasciitis and should be conisdered in any case of heel pain the has a neurological component to it.

{openx:185}

Baxter’s nerve entrapment, also known as inferior calcaneal nerve entrapment, is a relatively common but often overlooked cause of chronic heel pain. The Baxter’s nerve is the first branch of the lateral plantar nerve, and it runs beneath the abductor hallucis muscle before traveling along the medial side of the heel. Because of its position, it is vulnerable to compression as it passes between surrounding structures, particularly the abductor hallucis and the medial calcaneal tuberosity. This entrapment can mimic or coexist with plantar fasciitis, which is why it is frequently misdiagnosed.

The clinical presentation of Baxter’s nerve entrapment usually involves sharp, burning, or radiating pain on the inside of the heel that may worsen with prolonged standing, walking, or running. Unlike classic plantar fasciitis, which is typically most painful during the first steps in the morning, Baxter’s nerve pain can persist throughout the day and sometimes worsens with activity. Patients may also report tingling or numbness along the heel or arch, as the compressed nerve is both sensory and motor. Chronic cases can even lead to weakness of the abductor digiti quinti muscle in the foot.

Risk factors and causes often include repetitive overuse in runners, foot deformities such as flat feet or overpronation, and tightness of the abductor hallucis muscle. External factors, like ill-fitting shoes or excessive standing on hard surfaces, can also contribute to entrapment. In many athletes, the combination of repetitive heel impact and biomechanical stress creates a perfect environment for irritation of the nerve. Because these symptoms overlap with plantar fasciitis, imaging such as MRI or ultrasound, along with careful physical examination, is usually needed to confirm the diagnosis.

Treatment strategies for Baxter’s nerve entrapment focus on reducing nerve compression and inflammation. Conservative options include rest, orthotic devices to correct foot mechanics, stretching of the calf and abductor hallucis, and targeted physical therapy. Anti-inflammatory medications or corticosteroid injections may be used in persistent cases. For patients who do not respond to conservative care, surgical decompression of the nerve can be considered, which generally provides significant relief. Early recognition is important, as untreated entrapment can lead to chronic heel pain and functional limitations.

Most Useful Resources:
Baxters Nerve Entrapment (PodiaPaedia)
Baxter’s Neuritis (Medial Calcaneal Nerve Neuritis) (Podiatry Arena)
Baxter’s neuropathy secondary to plantar fasciitis (Podiatry Arena)
Baxters Nerve Entrapment (Podiatry TV)
Baxters nerve or plantar fasciitis? (Podiatry Experts)
Baxters Nerve Entrapment (Foot Health Forum)

{openx:185}

Gabapentin

Gabapentin’s connection to podiatry is that it can be used to treat chronic regional pain syndrome and restless leg syndrome which is common among patients seen in podiatry clinical practice. It is mainly used to treat epilepsy, but its use in conditions such as restless leg syndrome and other has increased over time due to clinical experience in its use.

{openx:185}

Gabapentin is a prescription medication originally developed to treat epilepsy, but it has since become more widely used for managing neuropathic (nerve-related) pain and certain mood disorders. It works by affecting the way nerves send signals to the brain, calming overactive electrical activity. While not chemically related to benzodiazepines or opioids, gabapentin influences neurotransmitters in a way that can help stabilize nerve firing and reduce sensations of pain, burning, or tingling often caused by conditions like diabetic neuropathy, postherpetic neuralgia (nerve pain after shingles), and fibromyalgia.

In clinical practice, gabapentin is valued for its versatility. Beyond its primary role in seizure control and nerve pain relief, it is sometimes prescribed off-label for conditions like anxiety, restless legs syndrome, or migraine prevention. Dosing typically starts low and is gradually increased, since the body needs time to adjust and the drug’s effectiveness depends on steady levels in the bloodstream. Unlike some stronger pain medications, gabapentin does not carry the same high risk of addiction, though misuse and dependence have been reported, especially when combined with other sedatives.

Like most medications, gabapentin comes with potential side effects. Common ones include dizziness, drowsiness, fatigue, and coordination problems, which can make activities like driving more hazardous until the body adapts. Some people also experience swelling in the extremities or mood changes. Serious side effects are less common but may involve severe allergic reactions or suicidal thoughts, which require immediate medical attention. Because gabapentin is processed by the kidneys, people with impaired kidney function usually need adjusted doses. Overall, gabapentin can be very effective when used appropriately under medical supervision, but careful monitoring is important to balance its benefits with its risks.

Most Useful Resources:
Gabapentin (PodiaPaedia)
NEURONTIN Prescribing Information (Pfizer)
Gabapentin (Wikipedia)

{openx:185}

Restiffic Foot Wrap for Restless Legs Syndrome

Restless legs syndrome is a common and extremely annoying problem. No one treatment works for each person, so often it is a trial and error to find the most useful treatment. There are many different drug options, including gabapentin, but each drug only seems to a small percentage of those with restless legs syndrome. There has been some recent discussion on the use of the Restiffic foot wrap, but it has not yet come to market. It appears to be a wrap that tight binds the foot. Those with Restless legs syndrome are always searching for cures as it has a significant affect on sleep quality and on their quality of life.

{openx:185}

The Restiffic Foot Wrap is a medical device designed to provide relief for individuals suffering from Restless Legs Syndrome (RLS), a condition characterized by uncomfortable sensations in the legs and an uncontrollable urge to move them, particularly at night. The wrap works by applying targeted pressure to specific points on the foot, which stimulates the peripheral nerves and helps reduce the neurological triggers that contribute to RLS symptoms. This pressure-based approach is non-invasive and drug-free, making it an appealing option for those seeking alternatives to medication.

One of the key benefits of the Restiffic Foot Wrap is its potential to improve sleep quality. Since RLS often disrupts rest due to constant leg movement and discomfort, alleviating these symptoms can lead to more restorative sleep. Better sleep not only enhances daily energy levels but also supports overall health, including cardiovascular and cognitive function. For many patients, consistent use of the foot wrap can help break the cycle of fatigue and nighttime restlessness, which are some of the most frustrating aspects of living with RLS.

Additionally, the wrap’s design prioritizes ease of use and comfort. It resembles a soft foot strap, adjustable to different sizes, and can be worn while lying in bed. Unlike pharmaceutical treatments, which may cause side effects or diminish in effectiveness over time, the Restiffic Foot Wrap offers a mechanical, low-risk solution. While results vary from person to person, clinical studies and user testimonials suggest that it can significantly reduce the severity of RLS symptoms, making it a valuable option for long-term management of this challenging condition.

Most Useful Resources:
RESTIFFIC™ Foot Wrap (PodiaPaedia)
The Restiffic Foot Wrap for Restless Legs Syndrome (Podiatry Arena)
Restiffic Foot Wrap for Restless Legs Syndrome (Its a Foot)

{openx:185}

Gowers Sign

Gowers Sign is an indicator of several neurological problems such as Duchennes Muscular Dystrophy. It is due to the weakness of the proximal muscles. The child as to raise from the ground from a supine position and use the hands to climb up the legs.

{openx:185}

Gowers’ sign is a classic clinical indicator of proximal muscle weakness, particularly involving the muscles of the pelvic girdle and lower limbs. It is named after Sir William Richard Gowers, a 19th-century British neurologist, who first described the maneuver in patients with muscular dystrophy. The sign is observed when a patient, asked to rise from a sitting or lying position on the floor, cannot do so directly. Instead, the individual uses their hands and arms to “walk” up their own body — pushing on the thighs and knees to achieve an upright stance. This compensatory motion reflects the weakness of the hip and thigh muscles that normally extend the trunk and hips.

The underlying mechanism behind Gowers’ sign lies in weakness of the proximal muscles, especially the gluteus maximus, quadriceps femoris, and hip extensors. In healthy individuals, these muscles provide sufficient power to raise the body smoothly. However, when they are weakened, as in conditions like Duchenne muscular dystrophy (DMD), the child cannot generate enough strength from the lower limbs alone. To compensate, they use their upper limbs to support and lift the trunk — a process often described as “climbing up the body.” This movement pattern is not only diagnostic but also provides insight into the severity and distribution of muscle involvement.

Clinically, Gowers’ sign is most commonly associated with Duchenne muscular dystrophy, but it may also appear in other disorders causing proximal weakness, such as Becker muscular dystrophy, limb-girdle muscular dystrophies, polymyositis, and spinal muscular atrophy. The presence of Gowers’ sign in a pediatric examination often prompts further diagnostic evaluation, including serum creatine kinase (CK) testing, genetic studies, and electromyography (EMG) to identify the underlying cause. Recognizing the sign early is critical because it may be one of the first observable manifestations of progressive muscle disease.

From a diagnostic standpoint, observing Gowers’ sign provides a simple yet powerful clue in neuromuscular assessment. It underscores the importance of functional testing in neurological examination, where careful observation of movement can reveal the nature of underlying pathology. In modern practice, though advanced imaging and genetic tools are available, bedside signs like Gowers’ remain invaluable in guiding clinical suspicion. Thus, Gowers’ sign not only serves as a window into muscle physiology but also as a testament to the enduring relevance of classical clinical observation in medicine.

Most Useful Resources:
Gowers’ Sign (PodiaPaedia)
Gower Sign (Podiatry FAQ)
Gowers Sign (Podiatry TV)

{openx:185}

The Ipswich Touch Test

The Ipswich Touch Test is a quick and sensitive test for diabetic neuropathy. The test is done by lightly touching the ends of the first, third and fifth toes of both feet (with a total of six toes) with the clinicians index finger for 1-2 seconds. They are asked to identify when the toe is touched. A reduced foot sensation using this test is generally considered when there being ≥ 2 areas that have lost sensation.

{openx:185}

The Ipswich Touch Test (IpTT) is a simple, quick, and effective screening method used to assess peripheral neuropathy—a condition often seen in people with diabetes that leads to loss of sensation in the feet. Peripheral neuropathy increases the risk of developing foot ulcers, which can eventually lead to serious complications like infections or even amputations. The Ipswich Touch Test was designed as an easy alternative to more specialized tools, allowing healthcare providers—or even trained caregivers—to identify patients who might have lost protective sensation in their feet.

The procedure itself is extremely straightforward. During the test, the examiner lightly touches the tips of the patient’s first, third, and fifth toes on each foot using the index finger for about 1–2 seconds. The key is to use a light touch—enough for someone with normal sensation to feel, but gentle enough that those with neuropathy may not. The patient should have their eyes closed throughout the test to ensure they are responding to sensation rather than visual cues. If the patient fails to feel two or more touches out of the six possible points, it suggests a loss of protective sensation, indicating peripheral neuropathy.

One of the main advantages of the Ipswich Touch Test is its accessibility and simplicity. Unlike other diagnostic tools such as the 10g monofilament or vibration perception tests, the IpTT requires no equipment, making it ideal for use in low-resource settings or community screenings. It’s cost-free, quick (taking less than a minute per patient), and can be easily taught to non-specialist staff or even family members caring for someone with diabetes. Despite its simplicity, studies have shown that the Ipswich Touch Test has a high sensitivity and specificity, making it a reliable tool for early neuropathy detection.

In summary, the Ipswich Touch Test plays a crucial role in preventive diabetic foot care. By identifying individuals at risk of neuropathy early, it enables timely interventions—like patient education, proper footwear, and regular foot checks—that can prevent ulcers and amputations. Its simplicity makes it a valuable public health tool, promoting awareness and empowering both healthcare professionals and patients to take proactive steps in managing diabetic foot health.

Most Useful Resources:
The Ipswich Touch Test for diabetic neuropathy (Podiatry Arena)
Ipswich Touch Test (PodiaPaedia)

{openx:185}